Cognition Therapeutics Common Stock

Cognition Therapeutics (CGTX) currently reports a common stock of $95K as of June 2026. That compares with $65K in the prior-year period — up 46.2% year over year. Use the charts on this page to explore Cognition Therapeutics's common stock history and peer comparisons.

Cognition Therapeutics's common stock increased from $65K to $95K — a 46.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cognition Therapeutics reported $95K in common stock as of June 2026. That compares with $65K in the prior-year period — up 46.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $95K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cognition Therapeutics, and consider following CGTX for alerts when major investors trade the stock.

Cognition Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $95K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CGTX with unrelated industries.